Our study identifies circ-PRMT1 as a clinically significant predictor of colorectal adenocarcinoma progression, with overexpression detected in 83.7% of tumors compared to matched non-cancerous tissues. Here, PRMT1 is linked to colorectal adenocarcinoma.